Ashwin Balagopal, MD

• Chair, ACTG 5335s
• Investigator ACTG 5329 and ACTG 5334s
• Investigator, Hepatitis Transformative Science Group (Feb 2016)

REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....

This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...

IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...

A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...

TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...

Johns Hopkins University Baltimore-India Clinical Trials Unit